Analysts Set Baxter International Inc. (NYSE:BAX) Price Target at $30.11

Baxter International Inc. (NYSE:BAX) has been assigned a consensus rating of “Hold” from the ten analysts that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $30.1111.

BAX has been the subject of a number of analyst reports. Barclays lowered their price target on shares of Baxter International from $41.00 to $36.00 and set an “overweight” rating for the company in a report on Monday, August 4th. The Goldman Sachs Group downgraded shares of Baxter International from a “buy” rating to a “neutral” rating and set a $25.00 price target for the company. in a report on Friday, August 1st. Wells Fargo & Company lowered their price target on shares of Baxter International from $33.00 to $24.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Wall Street Zen downgraded shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $25.00 price objective (down previously from $36.00) on shares of Baxter International in a research note on Monday, August 4th.

Institutional Trading of Baxter International

Several institutional investors have recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC bought a new stake in Baxter International in the second quarter worth about $40,000. Rexford Capital Inc. bought a new stake in shares of Baxter International during the second quarter valued at approximately $271,000. MUFG Securities EMEA plc bought a new stake in shares of Baxter International during the second quarter valued at approximately $46,000. Captrust Financial Advisors raised its stake in shares of Baxter International by 5.5% during the second quarter. Captrust Financial Advisors now owns 53,933 shares of the medical instruments supplier’s stock valued at $1,633,000 after acquiring an additional 2,813 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S raised its stake in shares of Baxter International by 21.4% during the second quarter. BI Asset Management Fondsmaeglerselskab A S now owns 24,356 shares of the medical instruments supplier’s stock valued at $737,000 after acquiring an additional 4,293 shares in the last quarter. Institutional investors own 90.19% of the company’s stock.

Baxter International Stock Down 1.4%

Shares of NYSE:BAX opened at $22.55 on Friday. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30. Baxter International has a 12 month low of $21.33 and a 12 month high of $39.57. The company has a 50-day moving average price of $24.64 and a 200 day moving average price of $28.73. The company has a market cap of $11.58 billion, a price-to-earnings ratio of -75.15, a PEG ratio of 0.74 and a beta of 0.61.

Baxter International (NYSE:BAX) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.60 by ($0.01). Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The business had revenue of $2.81 billion during the quarter, compared to the consensus estimate of $2.82 billion. During the same period in the previous year, the business posted $0.68 EPS. The firm’s revenue was up 4.3% on a year-over-year basis. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. As a group, equities research analysts predict that Baxter International will post 2.48 earnings per share for the current year.

Baxter International Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be paid a $0.17 dividend. The ex-dividend date of this dividend is Friday, August 29th. This represents a $0.68 annualized dividend and a yield of 3.0%. Baxter International’s dividend payout ratio (DPR) is presently -226.67%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.